PTCT Stock News 16.83 05/13/2014 12:29:54 Ptc Therapeutics Inc

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ptc Therapeutics Inc (PTCT) 16.83 $PTCT

PTC Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
PR Newswire - Tue May 06, 3:01PM CDT
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported its financial results for the first quarter ended March 31, 2014.

Nasdaq stocks posting largest percentage decreases
AP - Fri May 02, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Global Dengue Therapeutic Pipeline Review 2014
M2 - Mon Apr 28, 4:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m3qq9r/dengue_pipeline) has announced the addition of the "Global Dengue Therapeutic Pipeline Review 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies Involved in Therapeutics Development - GlaxoSmithKline plc - GenVec, Inc. - Merck & Co., Inc. - Takeda Pharmaceutical Company Limited - FIT Biotech Oyj - Biological E. Limited - Biotron Limited - Sarepta Therapeutics, Inc. - Medivir AB - NanoViricides, Inc. - SIGA Technologies, Inc. - Panacea Biotec Limited - Bharat Biotech International Limited - Protein Potential, LLC - TechnoVax, Inc. - MacroGenics, Inc. - PTC Therapeutics, Inc. - Chimerix, Inc. - Immunotope, Inc. - Immunovaccine, Inc. - VaxInnate Corporation - Janssen Pharmaceuticals, Inc. - Cocrystal Discovery, Inc. - PaxVax - AltraVax Inc. - Oneness Biotech Co., Ltd. - Arbovax, Inc. - Sanofi Pasteur SA - Themis Bioscience GmbH - Agilvax, Inc. - Humabs BioMed SA - Codagenix, Inc. Drug Profiles - Dengue Vaccine - DENVax - TetraVax-DV Vaccine-Admixture TV003 - Attenuated Tetravalent Lyophilized Dengue Vaccine - celgosivir hydrochloride - TetraVax-DV Vaccine-Admixture 1 - TetraVax-DV Vaccine-Admixture 2 - TetraVax-DV Vaccine-Admixture TV005 - V-180 - Dengue Vaccine - DENV-1 PIV - ST-148 - DengueCide - TVX-005 - Dengue Vaccine - AVI-6006 - Dengue Vaccine - DV2G460P - squalamine lactate - ST-610 - Dengue Fever Vaccine - Dengue Tetravalent Vaccine - Vaccine For Dengue - Dengue Vaccine - CLEC5A mAb - Dengue Virus Vaccines - Dengue Virus Vacine - Dengue Vaccine - GREDEN/V1-4 - Subunit Vaccine For Dengue - Dengue Vaccine - DEN-2-JE Virus Chimeric Plasmid Vaccine - Chimeric Live-Attenuated Dengue Vaccine - DENV-1/2 prM E Chimeric Vaccine - Vaccine For Dengue - Small Molecules to Inhibit Furin for Dengue - DV-2-DeltaGVII - DV-2-DeltaLIG - Mult. mAbs/DARTs - Small Molecule for Dengue - Vaccine For Dengue Fever - Small Molecule for Viral Infections - Small Molecule to Inhibit NS3 Protease for Dengue - Viral PMO-X - Small Molecule For Dengue - LCTA-949 - DiTU - BG-323 - Small Moleucles to Activate AMPK for Dengue - Small Molecules to Inhhibit Serine Protease for Viral Infections - Subunit Vaccine for Dengue Fever For more information visit http://www.researchandmarkets.com/research/m3...e_pipeline

PTC Therapeutics to Present at Upcoming Investor Conferences
PR Newswire - Wed Apr 23, 3:30PM CDT
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will present a company overview at two upcoming investor conferences:

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
PR Newswire - Tue Apr 22, 3:30PM CDT
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2014 financial results on Tuesday, May 6, 2014 at 4:30 p.m. (ET) after the closing of the market.

PTC Therapeutics grants stock option to four new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Tue Apr 22, 5:04AM CDT
Biopharmaceutical company PTC Therapeutics (NasdaqGS TCT) said on Monday that it has awarded non-statutory stock options to purchase an aggregate of 9,800 shares of its common stock to four new employees.

PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire - Mon Apr 21, 12:00PM CDT
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 17, 2014 it granted non-statutory stock options to purchase an aggregate of 9,800 shares of its common stock to four new employees. The grant was made pursuant to the NASDAQ inducement grant exception as a component of our new hires' employment compensation.

Why PTC Therapeutics, Inc. Shares Dipped
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 07, 12:37PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of PTC Therapeutics , a biopharmaceutical...

PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
PR Newswire - Thu Mar 06, 3:00PM CST
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported its financial results for the fourth quarter and full-year ended December 31, 2013.

Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC
PR Newswire - Wed Mar 05, 2:30PM CST
Editor Note: For more information about this release, please scroll to bottom.

PTC Therapeutics To Present At The Cowen & Company 34th Annual Health Care Conference
PR Newswire - Fri Feb 28, 7:00AM CST
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will present a company overview at the Cowen & Company 34th Annual Health Care Conference on Wednesday, March 5th at 9:20 am ET at the Marriott Copley Plaza Hotel in Boston.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BrightView's Tumbling Shares Prompt Investor Inquiry

Updated Category News Views 0

BrightView's Financial Quagmire: Investor Alarm Bells Ring Just when you thought it couldn't get any rockier for BrightView Holdings (NYSE: BV), here comes another gut punch. Their Development Services segment—once a promising player—felt like it dropped off a cliff, tumbling by almost 18%. If you were counting on those revenues to keep things afloat, well, it seems...

Continue Reading
Consumer Debt Balloons to $18.56T Amid Economic Jitters

Updated Category News Views 35

The Debt Tide Keeps Rising Alright, let’s dive calloused knuckles first into what's cooking with U.S. consumer debt these days. Shockwaves through the wallet world this past September—consumer debt surged to a jaw-dropping $18.56 trillion. That's a hefty climb of 2.9% year-over-year, and for anyone keeping score, it wasn't just about mortgages hiking up their pricey...

Continue Reading
Lemonade Preps for 2026 Investor Day with Webcast Plans

Updated Category News Views 35

Lemonade's Investor Day Goes Hybrid Everyone's got their eyes peeled on Lemonade's upcoming Investor Day scheduled for November 17, 2026. It's like taking a peek behind the curtain of a magician's act—will we be wowed or left scratching our heads? This year's spectacle happens in New York but gives attendees the luxury of attendance however they fancy. Lemonade's...

Continue Reading
Azazie Pops Up in Citrus Fields with Bridal Bliss

Updated Category News Views 44

Azazie Steps into the Sunshine State Alright, here we go—Azazie's taking their whole bridal catalogue circus down to the heart of Florida's citrus country this November. Polk City, mark your calendars for November 14. Now, I'm not the type who usually gets jazzed about gowns and lace, but this pop-up event at Ever After Farms Citrus just might turn a few heads, even...

Continue Reading
Clarivate's Upcoming Conference Presentation: What to Expect

Updated Category News Views 24

Conference Time: Will Clarivate Deliver the Goods? Grab your calendars, folks. November 18 is when Clarivate Plc is stepping into the spotlight at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference. Their bigwigs, Matti Shem Tov, the CEO, and Michael Easton, the CFO, will be there to spill the beans. They’re set to take the mike...

Continue Reading
Brent Crude's Tumult: Oil Giants Weather Market Shifts

Updated Category News Views 59

Oil Market Faces Uncertain Waves The energy sector's a rough sea these days, with Brent crude prices yo-yoing close to that $100 mark. If you're looking for clarity, don't hold your breath—the EIA's latest report suggests we’re sticking near this price for the foreseeable future before easing into more palatable waters come late 2027. But we ain't there yet, as U.S....

Continue Reading
LITEON Pushes AI Data Centers with Optical Tech

Updated Category News Views 50

Electronics Meet the Future in Munich When the tech-savvy brains of LITEON hit Munich for electronica 2026, they didn't hold back. This wasn't just your run-of-the-mill showcase; it was a full-on display of technological muscle. Among the dazzling spread were their high-speed optical interconnects. Now, if you're not dialed into what that is, think of it like the train...

Continue Reading
Peanuts and Diabetes: A Surprising Health Link

Updated Category News Views 95

A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...

Continue Reading
Group 1 Automotive Expands with Lexus Gwinnett Acquisition

Updated Category News Views 40

Unifying the Landscape: Group 1's Bold Move with Lexus Gwinnett Another piece of the puzzle drops into place as Group 1 Automotive continues its aggressive campaign to unify its dealership network. The latest acquisition sees the Hennessy Lexus of Gwinnett rebranded as Lexus Gwinnett, adding another notch to their belt in the bustling Atlanta-market corridor. Group 1's...

Continue Reading
Kava Meets Comics: A New Spot in King of Prussia

Updated Category News Views 49

A Social Revolution in King of Prussia Look, this ain't your typical bar review. We're talking about the Uncanny Comics and Kava Bar at King of Prussia Mall—where comic books, collectible treasures, and good company collide with a South Pacific vibe. Kava: Beyond Just Another Drink First off, if you're scratching your head about kava, don't fret. It's a beverage made...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Call for MSA Safety: Key Details Inside

Updated Category News Views 213

MSA Safety Earnings Conference Call Announcement MSA Safety Incorporated (NYSE: MSA), a pioneering force in the safety industry, is set to hold its fourth quarter and full-year earnings conference call. This event will take place on Thursday, February 12, 2026, at 10:00 a.m. Eastern Time. The call aims to provide investors and stakeholders with insights into the company's...

Continue Reading
Geotab GO Anywhere Tracker Launches for European Asset Management

Updated Category News Views 258

Introducing the Geotab GO Anywhere Asset Tracker Geotab Inc., a recognized pioneer in connected vehicle and asset solutions, has launched the GO Anywhere™, a reliable asset tracking device tailored for European markets. This innovative battery-powered tracker empowers businesses to manage and monitor their critical assets more effectively than ever before, especially in...

Continue Reading
Rosen Law Firm Investigates TechTarget for Potential Shareholder Claims

Updated Category News Views 588

The Investigation into TechTarget, Inc. The Rosen Law Firm is currently conducting a significant investigation concerning potential securities claims for shareholders of TechTarget, Inc. (NASDAQ: TTGT). This arises from serious allegations suggesting that TechTarget may have disseminated materially misleading business information to the investing public. This situation...

Continue Reading
Revolutionary Smart Lawn Mower Transforming Home Gardening

Updated Category News Views 271

Introducing the Future of Lawn Care with UBHOME At the forefront of innovation, UBHOME, a sub-brand of UBTECH Robotics, is set to transform home gardening with the unveiling of their groundbreaking Robotic Mower M10. This smart lawn mower, showcased at the upcoming CES event, promises to revolutionize how homeowners approach lawn care. With its integration of cutting-edge...

Continue Reading
Strategic Insights into Datadog's Options Trading Trends

Updated Category News Views 183

Understanding Datadog's Current Market Dynamics In the ever-evolving world of stock trading, significant investors known as whales have recently adopted a bearish view on Datadog. This trend is notable for anyone watching the dynamic and competitive landscape of tech stocks. Analyzing Recent Options Activity for Datadog Looking into the options trading history for Datadog...

Continue Reading